Mercer Global Advisors
JBIO

Mercer Global Advisors’s Jade Biosciences JBIO Stock Holding History

Mercer Global Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
+4,930
New +$103K ﹤0.01% 3766

Other funds holding JBIO

JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mercer Global Advisors's JBIO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Jade Biosciences (JBIO) in Q2 2026: 4,930 shares worth $110K. The stake represents ﹤0.01% of the portfolio and ranks #3766 among its holdings.

141 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Mercer Global Advisors held 4,930 shares of Jade Biosciences worth $110K as of Q2 2026.
  • Jade Biosciences was a new Mercer Global Advisors position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3766 holding.
  • 141 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.